CT-based AI system for quantitative and integrated management of acute respiratory distress syndrome in critical care

Read full text
Authors: Yuetan Chu, Jianpeng Wang, Peiyao Luo, Hui Chen, Zhongheng Zhang, Jiannan Zhang, Yilan Zhang, Yingnan Ju, Yaxin Xiong, Xiqing Luo, Jiuyue Sun, Hongyu Shi
+22 more Mingbo Zhao, Mingbo Zhao, Qiu Tinghui, Yiqi Wang, Quankuan Gu, Qiuyue Yang, Qiuyue Yang, Jiaman Guan, Yi Zhang, Renpei Lu, Ci Han, Yaoyu Gu, Changsong Wang, Kai Kang, Zhaowen Qiu, Xin Ge, Gongning Luo, Xin Gao, Kaijiang Yu, Mingyan Zhao, Mingyan Zhao, Xianglin Meng
Cited by: 1
References: 68

Abstract

Abstract Acute respiratory distress syndrome (ARDS) remains a major challenge in critical care, with mortality exceeding 40%. Its diagnosis and management depend on multi-step procedures, invasive arterial blood gas analysis, and subjective CT interpretation, often leading to inconsistency, delayed intervention, and increased procedural burden. To address these limitations, we develop AutoARDS, an all-in-one foundation model that transforms routine chest CT into a quantitative platform, enabling integrated and reproducible assessment of diagnosis, progression, oxygenation, physiology, and prognosis within a single, non-invasive workflow, thereby supporting faster and more standardized critical-care decisions. Technically, AutoARDS proposes to employ a multi-task pretraining strategy with adversarial perturbation, distilling routine but unstructured clinical data into unified representations for fine-grained pathological learning. Trained on over 50,000 CT volumes and validated across six medical centers (6,153 individuals), AutoARDS (1) established a reproducible CT-derived biomarker linking morphological injury with disease severity, enabling standardized tracking of pulmonary progression; (2) accurately diagnosed acute respiratory failure and ARDS (AUCs = 0.97 and 0.87), facilitating early recognition and reducing diagnostic delay; (3) directly estimated the P/F ratio (PCC = 0.83), outperforming SpO 2 -based monitoring for noninvasive severity stratification and ventilation management; and (4) predicted 28-day outcomes (time-averaged AUC = 0.79), providing complementary risk assessment for clinical planning. Further analyses confirm generalizability to ARDS-associated right ventricular dysfunction (AUC = 0.76) and revealed a positive shift image-derived age residuals, reflecting disease-related imaging patterns that resemble pulmonary aging. By bridging visual information with quantitative physiology, AutoARDS exemplifies a scalable blueprint for transforming chest CT into an integrated, quantitative platform for precise and reproducible critical-care management.

Fields of Study & Subjects

Respiratory Support and Mechanisms Ultrasound in Clinical Applications COVID-19 diagnosis using AI

Publication details

Journal / source
npj Digital Medicine
Publisher
Springer Science and Business Media LLC
Volume
9
Issue
1
Publication date
24 April 2026
Language
EN